Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.
In this month’s update, Dr. Tracy Pfeifer highlights the importance of fellowships and residents, how AlliedPro can help evolve staff's education, The Aesthetic Cruise 2026 is almost sold out, and the upcoming Facial and Rhinoplasty Symposium!
Dr. Tracy Pfeifer highlights key developments for The Aesthetic Society, including the new impact factor for Aesthetic Surgery Journal, evolving needs across generations of surgeons, plans for The Aesthetic MEET 2026, upcoming participation at ISAPS in Singapore, and an important cybersecurity alert for members.